David Westenberg
Stock Analyst at Piper Sandler
(1.07)
# 1844
Out of 5,329 analysts
181
Total ratings
42.39%
Success rate
2.82%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics | Maintains: Neutral | 180 200 | 177.4 | 12.74% | 7 | Apr 28, 2025 | |
NEOG Neogen | Maintains: Neutral | 7 5 | 5.13 | -2.53% | 12 | Apr 22, 2025 | |
AKYA Akoya Biosciences | Maintains: Neutral | 3 2 | 1.2 | 37.5% | 8 | Apr 14, 2025 | |
ELAN Elanco Animal Health | Maintains: Neutral | 16 12 | 9.47 | 26.72% | 9 | Mar 6, 2025 | |
TEM Tempus AI | Maintains: Neutral | 70 55 | 51.83 | 6.12% | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 205 | 151.63 | 35.2% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 22 16 | 17.27 | -7.35% | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 8 | 3.71 | 115.63% | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 205 | 155.72 | 31.65% | 11 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 21 18 | 7.29 | 146.91% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 34 50 | 48.88 | 2.29% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 75 70 | 47.19 | 48.34% | 10 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 2 | 1.1 | 81.82% | 7 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 11 | 7.37 | 49.25% | 11 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 240 260 | 241.29 | 7.75% | 3 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 185 190 | 76.54 | 148.24% | 15 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 435 510 | 471.58 | 8.15% | 10 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 3.12 | -3.85% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 5 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 170 165 | n/a | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 30 | n/a | n/a | 2 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 44 | n/a | n/a | 2 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 21, 2017 |